A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma. - NCT00716859-89052(Clinical Trial 231239)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Henderson |
|
State:
|
|
NV |
| Zip Code: |
|
89052 |
| Conditions: |
|
Glaucoma |
| Purpose: |
|
To assess the effectiveness of latanoprost 0.005% ophthalmic solution dosed once-daily and
timolol 0.5% dosed twice-daily in paediatric subjects of 18 years of age or under who are
diagnosed with glaucoma.
|
| Study summary: |
|
This study is no longer available. |
| Criteria: |
|
This study is no longer available. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
December 30, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|